Bellevue Group AG
- SEC CIK
- 0001674546
- Latest filing
- Aug 14, 2026
Holdings in Q1 2021
Holdings as of Mar 31, 2021, filed May 12, 2021. Long positions only.
- Positions
- 216
- No 13F data for Q4 2020
- Portfolio value
- $9.45B
- No 13F data for Q4 2020
Livermore's 13F data starts with Q1 2021, so this quarter has no previous quarter to compare with and changes are not shown.
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ELVElevance Health, Inc. | Stock | 385,548 | $138.4M | 1.5% | – | – | History |
| BIIBBiogen Inc. | COM | 558,400 | $156.2M | 1.7% | – | – | History |
| Radius Health, Inc.750469207 | COM NEW | 7,531,414 | $157.1M | 1.7% | – | – | – |
| ISRGIntuitive Surgical Inc | COM NEW | 220,775 | $163.1M | 1.7% | – | – | History |
| ABTAbbott Laboratories | Stock | 1,392,999 | $166.9M | 1.8% | – | – | History |
| FATEFate Therapeutics Inc | COM | 2,209,336 | $182.2M | 1.9% | – | – | History |
| MGNXMacrogenics Inc | COM | 6,027,926 | $192.0M | 2.0% | – | – | History |
| ALXNAlexion Pharmaceuticals, Inc. | COM | 1,308,728 | $200.1M | 2.1% | – | – | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 1,627,114 | $229.7M | 2.4% | – | – | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 4,537,092 | $234.3M | 2.5% | – | – | History |
| INCYIncyte Corp | COM | 3,005,700 | $244.3M | 2.6% | – | – | History |
| ARGXArgenx SE | SPONSORED ADR | 954,554 | $262.9M | 2.8% | – | – | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 1,376,704 | $295.8M | 3.1% | – | – | History |
| NBIXNeurocrine Biosciences Inc | Stock | 3,274,551 | $318.4M | 3.4% | – | – | History |
| MRNAModerna, Inc. | Stock | 2,809,950 | $368.0M | 3.9% | – | – | History |
| IONSIonis Pharmaceuticals Inc | COM | 8,984,234 | $403.9M | 4.3% | – | – | History |